Abstract:Background Recurrent pregnancy loss affects 1% to 2% of couples attempting childbirth. A large fraction of all cases remains idiopathic, which warrants research into monogenic causes of this distressing disorder. Methods and Results We investigated a nonconsanguineous Estonian family who had experienced 5 live births, intersected by 3 early pregnancy losses, and 6 fetal deaths, 3 of which occurred during the second trimester. No fetal malformations were described at the autopsies performed in 3 of 6 cases of fetal death. Parental and fetal chromosomal abnormalities (including submicroscopic) and maternal risk factors were excluded. Material for genetic testing was available from 4 miscarried cases (gestational weeks 11, 14, 17, and 18). Exome sequencing in 3 pregnancy losses and the mother identified no rare variants explicitly shared by the miscarried conceptuses. However, the mother and 2 pregnancy losses carried a heterozygous nonsynonymous variant, resulting in p.Val173Asp ( rs199472695 ) in the ion channel gene KCNQ1 . It is expressed not only in heart, where mutations cause type 1 long‐QT syndrome, but also in other tissues, including uterus. The p.Val173Asp variant has been previously identified in a patient with type 1 long‐QT syndrome, but not reported in the Genome Aggregation Database. With heterologous expression in CHO cells, our in vitro electrophysiologic studies indicated that the mutant slowly activating voltage‐gated K+ channel ( I Ks ) is dysfunctional. It showed reduced total activating and deactivating currents ( P <0.01), with dramatically positive shift of voltage dependence of activation by ≈10 mV ( P <0.05). Conclusions The current study uncovered concealed maternal type 1 long‐QT syndrome as a potential novel cause behind recurrent fetal loss. Nonstandard Abbreviations and Acronyms LQTS1 type 1 long‐QT syndrome PSAP population sampling probability QTcB the heart‐rate corrected QT interval based on the Bazett's formula QTc QT interval corrected for the heart rate RPL recurrent pregnancy loss WES whole‐exome sequencing Clinical Perspective What Is New? The current study uncovered concealed maternal type 1 long‐QT syndrome as a potential novel cause behind recurrent pregnancy loss. In vitro electrophysiological studies showed that the KCNQ1 p.V173D (c.518T>A) variant causes dysfunction and marked attenuation of the I Ks channel. What Are the Clinical Implications? This novel finding emphasizes the value of personalized medicine and the importance of in‐depth assessment of all potentially causative genotype‐to‐phenotype links. Genotype‐positive, phenotype‐negative subjects should avoid exposure to any exogenous risk factors, such as competitive sports or QT‐prolonging drugs. Early detection of KCNQ1 pathogenic variant carriers by testing among family members facilitates timely monitoring, treatment, and prevention of cardiac arrhythmias; clinical assessment of unexplained recurrent fetal losses should consider concealed maternal and/or fetal long‐QT syndrome as a possible cause. Recurrent pregnancy loss (RPL) is a disease defined by the spontaneous demise of ≥2 pregnancies, affecting ≈1% to 2% of women. 1 , 2 RPL has a long list of different causes, as both maternal and fetal, as well as combined factors, may be responsible. As a major known cause, up to 50% of products of conception of patients with RPL have gross genomic rearrangements. 3 However, it is estimated that roughly half of RPL cases remain truly idiopathic. Because the familial history of miscarriage increases the risk to RPL ≈2‐fold, 4 it is likely that some of these cases have unknown monogenic origins.<a clas -Abstract Truncated-

Recurrent Pregnancy Loss and Concealed Long-QT Syndrome.

Long QT Syndrome and Pregnancy

Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation.

Clinical Aspects of Type-1 Long-Qt Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 Gene.

Risk for Life-Threatening Cardiac Events in Patients with Genotype-Confirmed Long-Qt Syndrome and Normal-Range Corrected QT Intervals.

Risk of Aborted Cardiac Arrest or Sudden Cardiac Death During Adolescence in the Long-QT Syndrome

Risk Factors for Recurrent Syncope and Subsequent Fatal or Near-Fatal Events in Children and Adolescents with Long Qt Syndrome

Mutation-Specific Risk in Two Genetic Forms of Type 3 Long QT Syndrome

Long QT Syndrome Type 5-Lite: Defining the Clinical Phenotype Associated with the Potentially Proarrhythmic P.asp85asn-Kcne1 Common Genetic Variant.

Low foetal heart rate, a potentially ominous finding: case report

Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome.

Concealed Long-QT Syndrome with Rare KCNQ1 Gene Mutation in an Elderly Female: A Case Report

Unraveling Complexities in Genetically Elusive Long QT Syndrome

Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome.

Clinical Course And Risk Stratification Of Patients Affected With The Jervell And Lange-Nielsen Syndrome

Prognostic Implications of Mutation-Specific QTc Standard Deviation in Congenital Long QT Syndrome.

Clinical Implications For Patients With Long Qt Syndrome Who Experience A Cardiac Event During Infancy

Clinical Aspects of Type 3 Long-QT Syndrome: an International Multicenter Study.

Novel Compound Heterozygous Mutations in the KCNQ1 Gene Associated with Autosomal Recessive Long QT Syndrome (jervell and Lange‐Nielsen Syndrome)

[Clinical Practice Guidelines for Long Q-T Interval Syndrome].

[Analyses of triggers for recurrent cardiac events in 38 patients with symptomatic long QT syndrome]